BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11231121)

  • 1. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport.
    Hooiveld GJ; van Montfoort JE; Meijer DK; Müller M
    Eur J Pharm Sci; 2001 Feb; 12(4):525-43. PubMed ID: 11231121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport.
    Hooiveld GJ; van Montfoort JE; Meijer DK; Müller M
    Eur J Pharm Sci; 2000 Nov; 12(1):13-30. PubMed ID: 11121730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Hepatocyte-Like Cells with Functional Drug Transporters Directly-Reprogrammed from Mouse Fibroblasts and their Potential in Drug Disposition and Toxicology.
    Wu ZT; Yao D; Ji SY; Ni X; Gao YM; Hui LJ; Pan GY
    Cell Physiol Biochem; 2016; 38(5):1815-30. PubMed ID: 27160211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From blood to bile: recent advances in hepatobiliary transport.
    Arrese M; Accatino L
    Ann Hepatol; 2002; 1(2):64-71. PubMed ID: 15115970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver.
    Vos TA; Hooiveld GJ; Koning H; Childs S; Meijer DK; Moshage H; Jansen PL; Müller M
    Hepatology; 1998 Dec; 28(6):1637-44. PubMed ID: 9828229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.
    Feng B; Xu JJ; Bi YA; Mireles R; Davidson R; Duignan DB; Campbell S; Kostrubsky VE; Dunn MC; Smith AR; Wang HF
    Toxicol Sci; 2009 Apr; 108(2):492-500. PubMed ID: 19223659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of biliary drug efflux pump expression by hormones and xenobiotics.
    Fardel O; Payen L; Courtois A; Vernhet L; Lecureur V
    Toxicology; 2001 Oct; 167(1):37-46. PubMed ID: 11557128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of hepatocellular transporters.
    Pauli-Magnus C; Meier PJ
    Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport.
    Elferink RP; Tytgat GN; Groen AK
    FASEB J; 1997 Jan; 11(1):19-28. PubMed ID: 9034162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of synthesis and trafficking of canalicular transporters and its alteration in acquired hepatocellular cholestasis. Experimental therapeutic strategies for its prevention.
    Crocenzi FA; Mottino AD; Roma MG
    Curr Med Chem; 2004 Feb; 11(4):501-24. PubMed ID: 14965230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.
    Rippin SJ; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2001 Apr; 33(4):776-82. PubMed ID: 11283839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
    Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
    Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes.
    Borlak J; Klutcka T
    Xenobiotica; 2004; 34(11-12):935-47. PubMed ID: 15801539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.
    Zollner G; Thueringer A; Lackner C; Fickert P; Trauner M
    Digestion; 2014; 90(2):81-8. PubMed ID: 25196354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance transporters and modulation.
    Tan B; Piwnica-Worms D; Ratner L
    Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes.
    Mayer R; Kartenbeck J; Büchler M; Jedlitschky G; Leier I; Keppler D
    J Cell Biol; 1995 Oct; 131(1):137-50. PubMed ID: 7559771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells.
    Payen L; Courtois A; Langouët S; Guillouzo A; Fardel O
    Toxicology; 2001 Jan; 156(2-3):109-17. PubMed ID: 11164613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes.
    Jigorel E; Le Vee M; Boursier-Neyret C; Parmentier Y; Fardel O
    Drug Metab Dispos; 2006 Oct; 34(10):1756-63. PubMed ID: 16837569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.